Drug Shortage Report for ATROPINE INJECTION BP
| Report ID | 210686 |
| Drug Identification Number | 02432188 |
| Brand name | ATROPINE INJECTION BP |
| Common or Proper name | ATROPINE INJECTION BP |
| Company Name | HIKMA CANADA LIMITED |
| Market Status | MARKETED |
| Active Ingredient(s) | ATROPINE SULFATE |
| Strength(s) | 0.4MG |
| Dosage form(s) | SOLUTION |
| Route of administration | SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR |
| Packaging size | 1mL |
| ATC code | A03BA |
| ATC description | BELLADONNAAND DERIVATIVES, PLAIN |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | 2024-01-01 |
| Actual start date | |
| Estimated end date | 2024-04-01 |
| Actual end date | 2024-04-15 |
| Shortage status | Resolved |
| Updated date | 2024-04-16 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 5995 AVEBURY ROAD, SUITE 804 MISSISSAUGA, ONTARIO CANADA L5R 3P9 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v5 | 2024-04-16 | French | Compare |
| v4 | 2024-04-16 | English | Compare |
| v3 | 2024-01-02 | English | Compare |
| v2 | 2023-11-17 | French | Compare |
| v1 | 2023-11-17 | English | Compare |
Showing 1 to 5 of 5